Journal of Advances in Nanomaterials
Study on the Biological Safety of Arginine-modified Hydroxyapatite Nanoparticles
Download PDF (1227 KB) PP. 95 - 104 Pub. Date: December 20, 2016
Author(s)
- Min Yang1, Junjie Sun1, Yanzhong Zhao1, 2,**
1The Third Xiangya Hospital, Central South University, Changsha 410013, China - Zewen Song1, Haibin Zhang1, Shaihong Zhu1, 2
2Research Center for Medical Material and Instruments, Central South University, Changsha 410013, China
Abstract
Keywords
References
[1] S.H. Zhu, B.Y. Huang, K.C. Zhou, S.P. Huang, F. Liu, and Y.M. Li, “Hydroxyapatite Nanoparticles as a Novel Gene Carrier,”Journal of Nanoparticle Research, vol. 22,no. 5, pp.980–984,2005.
[2] T.N. Do, W.H. Lee, C.Y. Loo, A.V. Zavgorodniy, and R. Rohanizadeh, “Hydroxyapatite nanoparticles as vectors for gene delivery,”Therapeutic Delivery, vol. 3,no. 5, pp.623–632,2012.
[3] G. Zuo, Y. Wan, and Y. Zhang, “Preparation and characterization of a novel laminated magnetic hydroxyapatite for application on gene delivery,”Materials Letters, vol. 68, pp.225–227,2012.
[4] H. Sun, M. Jiang, and S.H. Zhu, “In vitro and in vivo studies on hydroxyapatite nanoparticles as a novel vector for inner ear gene therapy,”Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, vol. 43,no. 1, pp.51–57,2008.
[5] Y.Z. Zhao, S.H. Zhu, J. Tan, Y.Y. Huang, Zh.Y. Li, and K.C. Zhou,“Arginine modification and gene binding of hydroxyapatite nanoparticles,”Zhongguo Youse Jinshu Xuebao/chinese Journal of Nonferrous Metals,vol.20,no.6, pp.1203–1208,2010.
[6] G.H. Wang, Y.Z. Zhao, J.Tan, S.H. Zhu, and K.C. Zhou,“Arginine functionalized hydroxyapatite nanoparticles and its bioactivity for gene delivery,”Transactions of Nonferrous Metals Society of China,vol.25,no.2, pp.490–496,2015.
[7] Z. Siprashvil, F.A. Scholl, S.F. Oliver, A. Adams, C.H. Contag, P.A. Wender, and P.A. Khavari,“Gene transfer via reversible plasmid condensation with cysteine-flanked, internally spaced arginine-rich peptides,”Human Gene Therapy, vol.14, no.13, pp.1225–1233,2003.
[8] S. Futaki, W. Ohashi, T. Suzuki, M. Niwa, S. Tanaka, K. Ueda, H. Harashima, and Y. Sugiura, “Stearylated ariginine-rich peptides: A new class of transfection systems,”Bioconjugate Chemistry,vol.12, no.6, pp.1005–1011,2001.
[9] A.D.Maynard, “Nanotechnology:assessing the risk,”Nano Today, vol.1, no.2, pp.22-33,2006.
[10] W. Hannah, and P.B. Thompson,“Nanotechnology,risk and the environment:a review,”Journal of Environmental Monitoring Jem,vol.10, no.3, pp.291-300, 2008.
[11] A. Maynard, and D. Rejeski,“Too small to overlook,”Nature, vol.460, no.7252, pp.174-174, 2009.
[12] A.M. Fan, and G. Alexeeff, “Nanotechnology and nanomaterials: toxicology, risk assessment, and regulations,”Journal of Nanoscience and Nanotechnology, vol.10, no.12, pp.8646-8657, 2010.
[13] E.M. Forsberg,“Standardisation in the field of nanotechnology: some issues of legitimacy,”Science and Engineering Ethics,vol.18, no.4, pp.719-739,2012.
[14] A. Besinis,T. De-Peralta,C.J.Tredwin, and R.D.Handy, “Review of nanomaterials in dentistry: interactions with the oral microenvironment, clinical applications, hazards, and benefits,”ACS Nano, vol.9, no.3, pp.2255–2289,2015.
[15] R.Z. Legeros,“Properties of osteoconductive biomaterials: calciumphosphates,”Clinical Orthopaedics and Related Research,vol.395, no.395, pp.81-98,2002.
[16] H.Aoki, and T.Kutsuno, “An in vivo study on the reaction of hydroxyapatite-sol injected into blood,” Journal of Materials Science:Materials in Medicine,vol.11, no.2, pp.67-72,2000.
[17] J.L. Tang, and T.F. Xi,“Research status of the biological safety of nano-hydroxyapatite,” Journal of Clinical Rehabilitative Tissue Engineering Research,vol.11, no.5, pp.936-943,2007.
[18] G. Oberdorster, Z. Sharp, V. Atudorei, A. Elder, R. Gelein, A. Lunts, W. Kreyling, and C. Cox, “Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats,”Journal of Toxicology and Environmental Health Part A,vol.65, no.20, pp.1531-1543,2002.
[19] X. Wu, Y. Tan,H. Mao, and M. Zhang,“Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells,”International Journal of Nanomedicine,vol.5,no.1,pp.385-399,2010.
[20] Y.Sh. Dong,“The establishment and practice of a standard toxicopathological platform in drug safety evaluation,”Beijing: The Chinese people's Liberation Army Military Medical Science Academy,2012.
[21] D.R. Joseph, L. Demin, and W.B. Lin, “Nanoscale metal-organic frameworks for biomedical imaging and drug delivery,”Acc.chem.res,vol.44,no.10,pp.957-968,2011.
[22] J.N. Liu, X.L. Wei, H. Jiang, and W.Zh. Zhong,“Preparation and Transfer Efficiency of Modified PAMAM Dendrimer Gene Delivery,”Journal of Huazhong Agricultural University,vol.29,no.3,pp.333-334,2010.